Insights on the US Peripheral Neuropathy Treatment Market to 2020 | Industry Statistics, Emerging Demands, Forecast to 2026

The US peripheral neuropathy treatment market is estimated to grow at a CAGR of 4.6% during the forecast period. A significant rise in cancer incidences is the major factor leading to the increasing demand for peripheral neuropathy treatment in the country. As per the estimates by the American Cancer Society, in 2020, nearly 1.8 million new cancer cases will be diagnosed in the US. The rising cancer incidences are resulting adoption of chemotherapy which is most often used for cancer treatment. The therapy uses powerful chemicals to destroy fast-growing cells in the body. 

To Request a Sample of our Report on US Peripheral Neuropathy Treatment Market: https://www.omrglobal.com/request-sample/us-peripheral-neuropathy-treatment-market

Some chemotherapy drugs can cause peripheral neuropathy including podophyllotoxins (etoposide and tenoposide), vinca alkaloids (vincristine), cisplatin, and paclitaxel.  Other drugs that are utilized for cancer treatment include interferon and thalidomide can also cause peripheral neuropathy. This, in turn, is driving the demand for peripheral neuropathy treatment, which include steroids, antidepressant, opioids or narcotics, anti-seizure medications, and patches or creams of numbing medicine. Tricyclic antidepressants may provide relied on mild to moderate nerve pain. Drugs used for this class include desipramine (Norpramin) and imipramine (Tofranil).  

Scope of the US Peripheral Neuropathy Treatment Market

Market Coverage

·        Market number available for 2019-2026

·        Base year- 2019

·        Forecast period- 2020-2026

·        Segment Covered- By Type and Application

·        Competitive Landscape- Pfizer Inc., Grünenthal GmbH, Bristol Myers Squibb Co., and Eli Lilly and Co.

Recent Strategic Initiatives in the US Peripheral Neuropathy Treatment Market

·        In July 2020, Grünenthal declared that its subsidiary Averitas Pharma, Inc. gained US FDA approval for QUTENZA (capsaicin) 8% patch to treat neuropathic pain related to diabetic peripheral neuropathy of the feet in adults. It is a topical, non-opioid pain, and non-systemic treatment that is delivered in the patch form. It is the first and only treatment of its kind that delivers prescription-strength capsaicin directly into the skin. The patch can offer sustained relief for up to three months. It has no known drug-drug interactions. Its adverse reactions comprise application site reactions, such as pruritus, erythema, and pain. 

·        In July 2019, Rising Pharmaceuticals, Inc. declared the introduction of a generic version of Lyrica, (pregabalin) capsules in the US. These capsules are intended for neuropathic pain management related to diabetic peripheral neuropathy, for the management of fibromyalgia, and others. It is one of the largest volume launches for Rising Pharmaceuticals in 2019 and will offer a cost-effective treatment alternative for patients suffering from debilitating neuropathic pain conditions. 

(Get 15% Discount on Buying this Report)

A full Report of US Peripheral Neuropathy Treatment Market is Available at: https://www.omrglobal.com/industry-reports/us-peripheral-neuropathy-treatment-market

US Peripheral Neuropathy Treatment Market-Segmentation

By Type

·        Antidepressants

·        Pain Relievers

·        Antiseizure 

·        Others 

By Application

·        Diabetes 

·        Chemotherapy-Induced 

·        Others

Company Profiles

·        Achelios Therapeutics, Inc.

·        Acorda Therapeutics, Inc.

·        Amneal Pharmaceuticals LLC

·        Assertio Therapeutics, Inc.

·        Bristol Myers Squibb Co.

·        Eli Lilly and Co.

·        Innovus Pharmaceuticals, Inc.

·        Johnson & Johnson Services Inc.

·        Pfizer Inc.

·        Rising Pharma Holdings, Inc.

Reasons to buy from us –

1.  We cover more than 15 major industries, further segmented into more than 90 sectors.

2.  More than 120 countries are for analysis.

3.  Over 100+ paid data sources mined for investigation.

4.  Our expert research analysts answer all your questions before and after purchasing your report.

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

Comments

Post a Comment

Popular posts from this blog

European Data Backup and Recovery Market Size, Share, Analysis, Industry Report and Forecast 2019-2025

  European Data Backup and Recovery Market are expected to reach $5.7 billion in 2027, growing at a CAGR of 9.5% during the forecast period (2021-2027). Factors responsible for the growth of the market in Europe are well-developed telecommunication infrastructure, high internet penetration, high adoption of cloud-based devices among people and organization. Regulations regarding the data localization such as GDPR by the European Union and countries own data localization and protection act are providing growth to the market. Major economies which are expected to hold a considerable market are UK, Germany, France, Italy, and Spain. These economies are part of the European Union, which covers most of the continent. The aim of the European Union was to increase economic cooperation and encourage free trade among countries. To Request a Sample of our Report on European Data Backup and Recovery Market :   https://www.omrglobal.com/request-sample/european-data-backup-recovery-...
Read more

Insect Repellent Market Is Likely to Experience a Tremendous Growth by 2031

This informative Insect Repellent Market report provides new method and covers foremost regions such as Latin America, Middle East, North America, Europe, Africa and Asia Pacific. Making most out of the consumer insights and market opportunities, market players can boost up the revenue rate of their business. It also permits key organizations to make communication with customers and know their demands for making right investment in the product development. By increasing the product portfolio by referring the important market data provided in this Insect Repellent Market research report, key players can grow and expand their business forward. Continuously developing customer demands are also described in this global report to help new entrants make required changes in the final product launch and then bring into the market. It becomes easy for key players to prioritize the demands and requirements of target audience and have complete understanding of end-user experience with the help o...
Read more

Asia-Pacific Urban Air Mobility Market Growth, Size, Share, Industry Report and Forecast 2019-2025

The Asia-Pacific urban air mobility market is estimated to grow at a CAGR of 12.6% during the forecast period. The Asia-Pacific urban air mobility market is segmented on the basis of component and operation. Based on the component, the market is further segmented into infrastructure and platform. The infrastructure segment is further segmented into charging stations, traffic management, and others whereas, the platform segment is further classified into air taxi, personal air vehicle, air ambulance, and others. The platform segment dominated the global urban air mobility market. To Request a Sample of our Report on Asia-Pacific Urban Air Mobility Market :   https://www.omrglobal.com/request-sample/asia-pacific-urban-air-mobility-market Asia-Pacific is home to several emerging economies and is seen as the potential market for the UAM owing to growing urbanization coupled with increasing traffic congestion and increasing high-income groups in the region. The growth of the As...
Read more